Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
1(50.0%)
N/A
1(50.0%)
2Total
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06073171Not ApplicableRecruiting

Genomic Study of Cutis Tricolor

Role: collaborator

NCT03362684Phase 3Completed

PETACC-8 miR-31-3p and miR-31-5p Ancillary Study

Role: lead

NCT01646866Completed

Early Detection of Autism Spectrum Disorder in Children

Role: collaborator

NCT01452061Completed

Evaluating the Validity of a Genetic Risk Assessment Tool in Identifying Autism Spectrum Disorder

Role: collaborator

All 4 trials loaded